North America to dominate the Global Anticoagulant Reversal Drugs Industry, with a CAGR of 14.8% by 2032, Fact.MR Report
November 07, 2022 09:00 ET
|
FACT.MR
Rockville, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The anticoagulant reversal drugs market is likely to reach a valuation of US$ 1,137.35 Million in 2022. Furthermore, across the 2022-2032 period of...